Faricimab every 16 weeks offers similar benefits as aflibercept every eight weeks
Study shows that intravitreal injections may significantly slow the disease once thought untreatable
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy